Product Program year 2019 Source: CMS Open Payments

Fluzone Quadrivalent

Drug Vaccines

NDC 49281-419-10

Open in the dashboard

General payments

$276,108

10,767 payments

Research payments

$1,816,461

91 payments

Through program year 2019, $276,108 in general payments and $1,816,461 in research payments were reported against Fluzone Quadrivalent (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $276,108 10,767
2019 Research $1,816,461 91

Breakdown

Who paid General payments · program year 2019
  1. Sanofi Pasteur Inc. $276,065 10,764 payments
  2. Sanofi-Aventis U.S. LLC $30 2 payments
  3. Vaxserve Inc. $14 1 payment
Top recipients General payments · program year 2019
  1. Martin Mahoney Family Medicine · Buffalo, NY $10,881 4% · 8 payments
  2. Jaime Fergie Pediatric Infectious Diseases · Corpus Christi, TX $8,461 3% · 12 payments
  3. Gregory Poland Internal Medicine · Rochester, MN $8,453 3% · 7 payments
  4. Joseph Domachowske Pediatric Infectious Diseases · Syracuse, NY $8,032 3% · 8 payments
  5. Dale Bratzler Internal Medicine · Oklahoma City, OK $7,698 3% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatrics $85,875 31% · 3,219 practitioners
  2. Family Medicine $62,673 23% · 2,844 practitioners
  3. Internal Medicine $60,616 22% · 1,754 practitioners
  4. Pediatric Infectious Diseases Pediatrics $29,181 11% · 9 practitioners
  5. Infectious Disease Internal Medicine $8,358 3% · 36 practitioners

The top 5 of 97 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. New York $41,822 15% · 712 recipients
  2. Texas $32,528 12% · 638 recipients
  3. California $28,818 10% · 1,065 recipients
  4. Pennsylvania $25,632 9% · 517 recipients
  5. Missouri $18,240 7% · 219 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

10,767 general · 91 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record